---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-26-005686"
form_type: "8-K"
ticker: "EDSA"
cik: "0001540159"
company_name: "Edesa Biotech, Inc."
filed_at: "2026-08-20T20:15:17+00:00"
generated_at: "2026-08-20T20:16:09.567782+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Edesa Biotech prices $25.0M public offering of shares and warrants

## Summary
- Offering: 3,870,500 common shares plus warrants and 675,000 pre-funded warrants; combined price $5.50 per share/warrant unit.
- Gross proceeds ~$25.0M, net ~$23.1M after fees; expected close Aug 21, 2026.
- Common share warrants exercisable at $7.50, expire 18 months or 30 days after Phase 2 vitiligo topline data for EB06.
- Underwriters granted 30-day option for 681,825 additional shares and warrants.
- Proceeds for general corporate purposes incl. working capital, R&D and manufacturing.

## SEC filing metadata
- accession: 0001171843-26-005686
- form_type: 8-K
- ticker: EDSA
- cik: 0001540159
- company_name: Edesa Biotech, Inc.
- filed_at: 2026-08-20T20:15:17+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1540159/000117184326005686/0001171843-26-005686-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1540159/000117184326005686/f8k_081726.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-26-005686
- JSON: https://secwatch.observer/filing/0001171843-26-005686.json
- Plain text: https://secwatch.observer/filing/0001171843-26-005686.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.